ABAXIS, Inc. (NASDAQ:ABAX) announced a quarterly dividend on Thursday, July 27th, RTT News reports. Stockholders of record on Friday, September 1st will be given a dividend of 0.14 per share by the medical research company on Friday, September 15th. This represents a $0.56 annualized dividend and a dividend yield of 1.23%. The ex-dividend date is Wednesday, August 30th.

Shares of ABAXIS (NASDAQ:ABAX) opened at 45.50 on Tuesday. The stock has a market cap of $1.03 billion, a PE ratio of 32.13 and a beta of 0.81. The stock’s 50 day moving average price is $48.74 and its 200 day moving average price is $49.17. ABAXIS has a 1-year low of $44.12 and a 1-year high of $55.95.

ABAXIS (NASDAQ:ABAX) last released its quarterly earnings data on Thursday, July 27th. The medical research company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.33 by $0.05. ABAXIS had a net margin of 14.12% and a return on equity of 10.85%. The company had revenue of $58.26 million during the quarter, compared to the consensus estimate of $60.37 million. During the same quarter in the prior year, the company posted $0.30 earnings per share. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts anticipate that ABAXIS will post $1.13 EPS for the current fiscal year.

A number of research firms recently commented on ABAX. Bank of America Corporation restated an “underperform” rating and set a $42.00 price target on shares of ABAXIS in a research report on Wednesday, August 23rd. BidaskClub lowered ABAXIS from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 3rd. Zacks Investment Research lowered ABAXIS from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Stifel Nicolaus restated a “hold” rating and set a $48.00 price target on shares of ABAXIS in a research report on Friday, July 14th. Finally, Aegis began coverage on ABAXIS in a research report on Friday, June 9th. They set a “hold” rating and a $56.50 price target on the stock. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. ABAXIS has a consensus rating of “Hold” and an average price target of $48.63.

TRADEMARK VIOLATION WARNING: “ABAXIS, Inc. (ABAX) to Issue Quarterly Dividend of $0.14 on September 15th” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/29/abaxis-inc-abax-to-issue-quarterly-dividend-of-0-14-on-september-15th.html.

ABAXIS Company Profile

Abaxis, Inc is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force.

Dividend History for ABAXIS (NASDAQ:ABAX)

Receive News & Stock Ratings for ABAXIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABAXIS Inc. and related stocks with our FREE daily email newsletter.